ClinicalTrials.govcontrolled
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
ClinicalTrials.gov study NCT03813394. IPD Sharing: YES. Countries: 1. Publications: 4.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8